In this study, our objective was to identify clinical characteristics linked to cognitive impairment in PCC by examining the relationships between inflammation marker C-reactive protein (CRP), BMI, a proxy measure of insulin resistance (e.g., TG-HDL), and their combined effect on cognitive functioning among individuals with PCC. The gene discussed is CRP; the disease is Cognitive impairment.